Sotgiu, Giovanni and D'Ambrosio, Lia and Centis, Rosella and Bothamley, Graham Henry and Cirillo, Daniela M. and De Lorenzo, Saverio and Günther, Gunar and Kliiman, Kai and Muetterlein, Ralf and Spinu, Victor and Villar, Miguel and Zellweger, Jean-Pierre and Sandgren, Andreas and Huitric, Emma and Lange, Christoph and Manissero, Davide and Migliori, Giovanni Battista (2012) Availability of anti-tuberculosis drugs in Europe. European Respiratory Journal, Vol. 40 (2), p. 500-503. eISSN 1399-3003. Article.
Full text not available from this repository.
The emergence of multidrug-resistant tuberculosis (MDR-TB) and extensively drug-resistant tuberculosis (XDR-TB) represents a major threat to TB control globally and, specifically, in Europe. MDR-/XDR-TB is at large due to clinical mismanagement of drug-susceptible and drug-resistant TB cases as well as to transmission of resistant strains [1–3]. Continuous availability of quality-controlled drugs is a prerequisite to ensure correct clinical management of TB patients.
I documenti depositati in UnissResearch sono protetti dalle leggi che regolano il diritto d'autore
Repository Staff Only: item control page